artesunic acid has been researched along with Neovascularization, Optic Disc in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Feng, X; Fu, Y; Gao, Q; Hu, J; Li, C; Li, Y; Lin, L; Lin, X; Liu, B; Lu, L; Qian, X; Shao, W; Wen, X; Yang, Y; Zheng, H; Zheng, Q; Zhuo, Y | 1 |
| Gao, Q; He, H; Huang, Z; Li, Y; Lin, L; Qian, X; Yang, W; Yuan, Y; Zheng, Q; Zong, Y | 1 |
2 other study(ies) available for artesunic acid and Neovascularization, Optic Disc
| Article | Year |
|---|---|
A Pilot Clinical Study of Intravitreal Injection of Artesunate for Ocular Neovascularization.
Topics: Adolescent; Adult; Aged; Artesunate; Female; Humans; Intravitreal Injections; Male; Middle Aged; Neovascularization, Pathologic; Ophthalmic Solutions; Pilot Projects; Retinal Neovascularization; Young Adult | 2019 |
Small Molecular-Sized Artesunate Attenuates Ocular Neovascularization via VEGFR2, PKCĪ±, and PDGFR Targets.
Topics: Animals; Artemisinins; Artesunate; Macaca fascicularis; Macular Edema; Male; Neovascularization, Pathologic; Pilot Projects; Protein Kinase C-alpha; Rabbits; Receptors, Platelet-Derived Growth Factor; Retinal Neovascularization; Vascular Endothelial Growth Factor Receptor-2 | 2016 |